Contemporary Evaluation of Salvage Radiotherapy for Prostate Cancer: Radiotherapy Dose, Field Size, and Use of Hormone Therapy

被引：1
|
作者：
Jiang, Tommy [1 ]
Valle, Luca F. [2 ,4 ]
Kishan, Amar U. [2 ,3 ,5 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA
[2] Univ Calif Los Angeles, Dept Radiat Oncol, Los Angeles, CA USA
[3] Univ Calif Los Angeles, Dept Urol, Los Angeles, CA USA
[4] Vet Affairs Greater Angeles Healthcare Syst, Dept Radiat Oncol, Los Angeles, CA USA
[5] Univ Calif Los Angeles, Dept Radiat Oncol, Los Angeles, CA 90095 USA
来源：
EUROPEAN UROLOGY | 2023年 / 84卷 / 03期
关键词：
D O I：
10.1016/j.eururo.2023.05.012
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：257 / 259
页数：3
相关论文
共 50 条
  • [21] The dose factor in prostate cancer radiotherapy
    Miralbell, R
    RADIOTHERAPY AND ONCOLOGY, 2006, 78 : S28 - S29
  • [22] Salvage therapy for locally recurrent prostate cancer after external beam radiotherapy
    Stephenson A.J.
    Scardino P.T.
    Bianco Jr. F.J.
    Eastham J.A.
    Current Treatment Options in Oncology, 2004, 5 (5) : 357 - 365
  • [23] Meta-Analysis of Salvage Therapy Following Definitive Radiotherapy for Prostate Cancer
    Valle, L.
    Lehrer, E. J.
    Karnes, R. J.
    Reiter, R. E.
    Rettig, M.
    Calais, J.
    Nickols, N. G.
    Spratt, D. E.
    Dess, R. T.
    Steinberg, M. L.
    Nguyen, P. L.
    Davis, B. J.
    Zarosky, N.
    Kishan, A. U.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E875 - E875
  • [24] Is Hormone Therapy a Protective Factor for Late Hematuria After High-Dose Radiotherapy in Prostate Cancer?
    Zapatero, Almudena
    Garcia-Vicente, Feliciano
    Sevillano, David
    Martin de Vidales, Carmen
    Ferrer, Carlos
    Jose Torres, Juan
    Minguez, Ricardo
    Rabadan, Mariano
    UROLOGY, 2008, 72 (05) : 1130 - 1134
  • [25] Impact of hormone therapy on acute radiotherapy toxicity in the treatment of prostate cancer
    A B Jani
    J Gratzle
    M Myers
    Prostate Cancer and Prostatic Diseases, 2005, 8 : 224 - 228
  • [26] Salvage hypofractionated radiotherapy for prostate cancer: acute toxicity
    Saldi, S.
    Bellavita, R.
    Palumbo, I.
    Mariucci, C.
    Arena, E.
    Lupattelli, M.
    Podlesko, A.
    Russo, S.
    Dottorini, R.
    Bini, V.
    Aristei, C.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S725 - S725
  • [27] Salvage HIFU for recurrent prostate cancer after radiotherapy
    V Chalasani
    C H Martinez
    D Lim
    J Chin
    Prostate Cancer and Prostatic Diseases, 2009, 12 : 124 - 129
  • [28] Regression Discontinuity Analysis of Salvage Radiotherapy in Prostate Cancer
    Gild, Philipp
    Pompe, Raisa S.
    Seisen, Thomas
    Keeley, Jacob
    Tang, Hoang J.
    Bossi, Alberto
    Tilki, Derya
    Menon, Mani
    Abdollah, Firas
    EUROPEAN UROLOGY ONCOLOGY, 2021, 4 (05): : 817 - 820
  • [29] Combined radiotherapy and hormone therapy in unfavorable intermediate risk prostate cancer
    Makarova, K. S.
    Gumenetskaya, Yu. V.
    Biryukov, V. A.
    Rodina, T. A.
    Galitsyna, A. B.
    Shchukina, E. O.
    Karyakin, O. B.
    Ivanov, S. A.
    Kaprin, A. D.
    ONKOUROLOGIYA, 2023, 19 (01): : 76 - 84
  • [30] Radiotherapy and hormone therapy in patients with high-risk prostate cancer
    Nature Clinical Practice Oncology, 2008, 5 (1): : 8 - 8
12345